Skip to main content
. Author manuscript; available in PMC: 2009 Dec 16.
Published in final edited form as: J Nucl Med. 2008 Oct 16;49(11):1819–1827. doi: 10.2967/jnumed.108.054502

FIGURE 4.

FIGURE 4

Biodistribution comparing clearance properties of 64Cu-CB-TE2A-sst2-ANT (▲) and 64Cu-CB-TE2A-Y3-TATE (■) from blood (A), liver (B), kidney (C), tumor (D), adrenal glands (E), and pituitary gland (F). All data (n = 5; bars, ±SE) were decay-corrected. Note differences in y-axis scales. %ID = percentage injected dose.